AbbVie Inc. — Director's Dealing 2013

Aug 20, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-08-16

Reporting Person: Schumacher Laura J (EVP, Bus.Dev.,Ext.Aff.&GC)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-08-16	Common stock, $0.01 par value	M	1039	$30.2135	Acquired	246788	Direct
2013-08-16	Common stock, $0.01 par value	M	5425	$28.9148	Acquired	252213	Direct
2013-08-16	Common stock, $0.01 par value	M	4011	$34.4889	Acquired	256224	Direct
2013-08-16	Common stock, $0.01 par value	F	8928	$43.21	Disposed	247296	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-08-16	Option (right to buy)	$30.2135	M	1039	Disposed	2014-02-19	Common stock (1039)	Direct
2013-08-16	Option (right to buy)	$28.9148	M	5425	Disposed	2014-02-19	Common stock (5425)	Direct
2013-08-16	Option (right to buy)	$34.4889	M	4011	Disposed	2014-02-19	Common stock (4011)	Direct
2013-08-16	Option (right to buy)	$43.21	A	873	Acquired	2014-02-19	Common stock (873)	Direct
2013-08-16	Option (right to buy)	$43.21	A	4473	Acquired	2014-02-19	Common stock (4473)	Direct
2013-08-16	Option (right to buy)	$43.21	A	3582	Acquired	2014-02-19	Common stock (3582)	Direct

Footnotes

F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.